Comparing Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection for Treating Chronic Low Back Pain

What this Trial Is About

This research aims to compare the effects of thoracolumbar fascia mobilization and ultrasound-guided 5% dextrose injection on patients with nonspecific chronic low back pain. The study focuses on evaluating changes in pain, lumbar range of motion, and functional disability as primary objectives. Secondary goals include assessing long-term impacts on quality of life, proprioception, and the structural features of the thoracolumbar fascia such as thickness and echogenicity. Participants will be randomly assigned to one of three groups. The first group will receive thoracolumbar fascia mobilization through standardized myofascial release therapy, administered twice weekly for three weeks, totaling six sessions. The second group will receive an ultrasound-guided injection of 10 mL of 5% dextrose into the interfascial plane of the thoracolumbar fascia. The third group will undergo both treatments combined, following the described protocols. Those enrolled will undergo assessments measuring pain by the Visual Analog Scale, lumbar range of motion via digital inclinometer and Modified Schober Test, and functional disability using the Oswestry Disability Index, recorded at baseline and at one and three months post-intervention. Additional evaluations include quality of life surveys, ultrasound imaging of fascia characteristics, and tests of lumbar proprioception. Participation spans from initial screening through follow-ups to monitor safety and outcomes over several months.

Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain